{"nct_id":"NCT04233879","title":"Study of Doravirine/Islatravir (DOR/ISL 100 mg/0.75 mg) to Evaluate the Antiretroviral Activity, Safety, and Tolerability in Treatment-Naïve Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Infection (MK-8591A-020)","status":"COMPLETED","status_verified_date":"2025-07","start_date":"2020-02-28","start_date_type":"ACTUAL","primary_completion_date":"2022-11-17","primary_completion_date_type":"ACTUAL","completion_date":"2025-01-29","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["MRK"]}